Biocon Ltd. reported a 95% fall in net profit for the first quarter of financial year 2026.
The pharma company reported a consolidated bottom line of Rs 31.4 crore, a sharp fall from net profit of Rs 659.70 crore in the year-ago period.
Biocon Q1 Highlights (Consolidated, YoY)
Revenue up 14.8% to Rs 3,941.90 crore versus Rs 3,432.90 crore.
Net profit down 95% to Rs 31.40 crore versus Rs 659.70 crore.
Ebitda up 21% to Rs 748.90 crore versus Rs 620.40 crore.
Margin at 19% versus 18.1%
WRITTEN BY
ADVERTISEMENT
RECOMMENDED FOR YOU
Stock Market Today: All You Need To Know Going Into Trade On July 28
Jul 28, 2025
Stocks To Watch Today: Kotak Mahindra Bank, Aadhar Housing, Petronet LNG, Adani Green, Bank Of Baroda
Jul 28, 2025
Q1 Result Updates: J&K Bank Profit Rises 17%; SAIL Revenue Falls 12%
Jul 25, 2025
Q1 Result Updates: KFin Technologies Profit Rises 14%; IEX Revenue Rises Over 13%
Jul 25, 2025
POPULAR
1
Vantara Offers To Set Up Facility For Elephant Madhuri In Kolhapur Village
2
Home-Cooked Meals Become Cheaper In July
3
Supreme Court Urge Centre, IAF To Liberalise Definition Of Mother To Include Step-Mother For Family Pension
4
Average Cost Of Data Breach In India Rises 13% This Year: Report
5